日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Discovery of BMS-986408, a First-In-Class Dual DGKα and DGKζ Inhibitor that Unleashes PD-1 Checkpoint and CAR T-cell Immunotherapies

发现BMS-986408,一种首创的双重DGKα和DGKζ抑制剂,可激活PD-1检查点和CAR T细胞免疫疗法

Michael Wichroski # ,Si-Qi Liu # ,Lauren M Zasadil ,Joseph L Benci ,Patrick C Gedeon ,Kendall J Condon ,Suhasini Joshi ,Shana Posy ,Patrick Carlson ,Alison Maier ,Jiao Shen ,Rakeeb Kureshi ,Yuka Amako ,Tai Wang ,Ryan L Powles ,Yanyun Li ,Tho Lai ,Igor Katsyv ,Hongchen Qiu ,Huilin Qi ,Jessica Wong ,Dandan Zhao ,Dana Banas ,Joelle Onorato ,Gregory Locke ,Xueer Chen ,Wen-Chi Chou ,Erica Cook ,Abigail E Witt ,Christopher M Barbieri ,Hong Zhang ,Jonathan B Olsen ,Alba Font Tello ,Eugene Drokhlyansky ,Denise C Grünenfelder ,Louis Chupak ,Tyler A Longmire ,Jon C Jones ,Travis J Hollmann ,David G Kugler ,John N Feder ,Raphael Bueno ,John Wain ,Pallavur Sivakumar ,Yu Liu ,Stephanie K Dougan ,Cloud P Paweletz ,David A Barbie ,Emma Lees

Enhanced antitumor immunity by a novel small molecule HPK1 inhibitor

新型小分子 HPK1 抑制剂增强抗肿瘤免疫力

Dan You, Stephen Hillerman, Gregory Locke, Charu Chaudhry, Caitlyn Stromko, Anwar Murtaza, Yi Fan, Jennifer Koenitzer, Yali Chen, Stephanie Briceno, Rajarshi Bhadra, Elizabeth Duperret, Johnni Gullo-Brown, Chan Gao, Dandan Zhao, John Feder, Joshua Curtin, Andrew P Degnan, Godwin Kumi, Mark Wittman,